Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amphastar Pharma (AMPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 723,492
  • Shares Outstanding, K 46,200
  • Annual Sales, $ 255,170 K
  • Annual Income, $ 10,530 K
  • 36-Month Beta 1.66
  • Price/Sales 2.86
  • Price/Cash Flow 28.94
  • Price/Book 2.17

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.81 +5.74%
on 08/21/17
16.10 -2.73%
on 08/31/17
+0.44 (+2.89%)
since 08/18/17
3-Month
14.53 +7.78%
on 08/18/17
18.67 -16.12%
on 07/21/17
-1.48 (-8.63%)
since 06/20/17
52-Week
12.05 +29.96%
on 03/14/17
21.75 -28.00%
on 12/16/16
-5.60 (-26.34%)
since 09/20/16

Most Recent Stories

More News
Featured Company News - Dr. Reddy's Labs Announces the Launch of Anti-Depressant and Muscle Relaxant Tablets in the US

Research Desk Line-up: Amphastar Pharma Post Earnings Coverage

RDY : 35.46 (+2.60%)
AMPH : 15.57 (-0.57%)
Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2017 Wells Fargo Securities Healthcare Conference on Wednesday, September 6, 2017...

WFC : 53.82 (+0.86%)
AMPH : 15.57 (-0.57%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2017.

AMPH : 15.57 (-0.57%)
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2017, ended June 30, 2017, after the market closes on Wednesday, August 9, 2017,...

AMPH : 15.57 (-0.57%)
Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that a federal jury delivered a unanimous verdict in favor of Amphastar in a lawsuit brought by Momenta Pharmaceuticals, Inc. and Sandoz Inc....

MNTA : 16.70 (+0.30%)
AMPH : 15.57 (-0.57%)
Global Substance Abuse Treatment Market to Grow at a CAGR of 5.15% By 2021 - Key Vendors are Alkermes, Allergan, GSK & Pfizer

Research and Markets has announced the addition of the "Global Substance Abuse Treatment Market 2017-2021" report to their offering. The global substance abuse treatment market to grow at a CAGR of 5.15%...

AGN : 209.63 (-2.50%)
INSY : 8.85 (-1.78%)
AMPH : 15.57 (-0.57%)
ALKS : 50.07 (-0.93%)
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President, will be presenting at the Jefferies Global Healthcare Conference on Tuesday, June 6, 2017 at 10:00 a.m. Eastern...

AMPH : 15.57 (-0.57%)
Amphastar (AMPH) in Focus: Stock Moves 9.7% Higher

Amphastar Pharmaceuticals (AMPH) was a big mover last session, as the company saw its shares rise almost 10% on the day.

AMPH : 15.57 (-0.57%)
CORI : 10.57 (+1.83%)
Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 20 Annual Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16,...

AMPH : 15.57 (-0.57%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2017.

AMPH : 15.57 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Support & Resistance

2nd Resistance Point 16.10
1st Resistance Point 15.88
Last Price 15.57
1st Support Level 15.45
2nd Support Level 15.24

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.